Published

Psilocybin in Bipolar II Study Provides Preliminary Data on Safety

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Psychiatry HomeNew OnlineCurrent IssueFor Authors Podcast Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology-Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2024 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology-Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Psychiatry journal

Open source BibTeX RIS

Bibliographic context

Journal: JAMA Psychiatry
Date: 2023-12-05
Source: OpenAlex
DOI: 10.1001/jamapsychiatry.2023.4680
PubMed: 38055240

Authors

David B. Yaden Natalie Gukasyan Sandeep M. Nayak

Watch author

Topics and keywords

psilocybin Cancer Patients Safety Other Medicine Otorhinolaryngology Psychiatry Family medicine Neurology Psychedelics and Drug Studies Chemical synthesis and alkaloids Cannabis and Cannabinoid Research

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin in Bipolar II Study Provides Preliminary Data on Safety2023-12-05

Related papers

“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group TherapyPsychedelic Medicine · 2025-08-24 Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysisThe International Journal of Psychiatry in Medicine · 2025-04-24 Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 StudyPsychedelic Medicine · 2026-01-17 Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 StudyPsychedelic Medicine · 2025-12-22 Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative CarePalliative Medicine Reports · 2025-04-16 Use of Psilocybin in the Treatment of Mental Disorders: Systematic Review of Clinal TrialsJournal of Complementary Medicine & Alternative Healthcare · 2024-09-16 Psilocybin-Assisted Therapy for Brain Cancer Related Existential Distress: A Case-ReportJournal of Palliative Medicine · 2024-09-11 Psilocybin Use in Palliative Care #464Journal of Palliative Medicine · 2023-08-31